SCHEMBL3069324

SCHEMBL3069324

C=C(C)CC1CCCCC1

nearest known ligand 0.40

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
EPHX1 P07099 2/20 0.40
HPGD P15428 1/20 0.40
KMT2A Q03164 1/20 0.40
CYP1A2 P05177 1/20 0.37
ADH1B P00325 1/20 0.34
ADH1C P00326 1/20 0.34
ADH1A P07327 1/20 0.34
ADH4 P08319 1/20 0.34
ADH7 P40394 1/20 0.34
EPHX2 P34913 2/20 0.33
ACHE P22303 1/20 0.32
CHRM5 P08912 2/20 0.32
ADRA2C P18825 1/20 0.32
CHRM2 P08172 1/20 0.32
CHRM4 P08173 1/20 0.32
CHRM1 P11229 1/20 0.32
DPP4 P27487 1/20 0.32
NPC1 O15118 1/20 0.32
TDP1 Q9NUW8 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14354172 1.00 EPHX1 (0.40) EPHX1HPGDKMT2ACYP1A2ADH1B
SCHEMBL7003406 0.97
SCHEMBL22305020 0.80 DPP4 (0.35) DPP4
SCHEMBL5117 0.78 EPHX1 (0.43) EPHX1HPGDKMT2ACYP1A2ADH1B
SCHEMBL5708 0.78 EPHX1 (0.43) EPHX1HPGDKMT2ACYP1A2ADH1B
SCHEMBL3032405 0.78 EPHX1 (0.43) EPHX1HPGDKMT2ACYP1A2ADH1B
SCHEMBL95966 0.78 EPHX1 (0.43) EPHX1HPGDKMT2ACYP1A2ADH1B
SCHEMBL9979182 0.78 EPHX1 (0.43) EPHX1HPGDKMT2ACYP1A2ADH1B
SCHEMBL9253989 0.78 EPHX1 (0.43) EPHX1HPGDKMT2ACYP1A2ADH1B
SCHEMBL12166729 0.77 SHBG (0.34)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4105845-A NICKEL SOURCE COMPLEX WITH TITANIUM OR VANADIUM COMPOUND PHILLIPS PETROLEUM COMPANY (US) 1978-08-08 US claimed
EP-4194457-A1 COMPOUND FOR TARGETING AND DEGRADING PROTEIN, AND PREPARATION METHOD THEREFOR AND USE THEREOF Shanghai Leadingtac Pharmaceutical Co., Ltd. (CN) 2023-06-14 EP disclosed
CN-101014629-B Catalysts for olefin polymerization, process for production of olefin polymers, olefin copolymers, novel transition metal compounds, and process for production of transition metal compounds MITSUI CHEMICALS INC 2011-06-22 CN disclosed
US-20100267908-A1 Catalyst for olefin polymerization, process for producing olefin polymer, olefin copolymer, novel transition metal compound, and process for producing transition metal compound MITSUI CHEMICALS, INC. 2010-10-21 US disclosed
US-7348065-B2 Slipping property imparting agent for clear coating and clear coating paper having the agent applied thereon NIPPON PAPER INDUSTRIES CO., LTD. (JP) 2008-03-25 US disclosed
US-20070260026-A1 Catalyst for Olefin Polymerization Process for Producing Olefin Polymer, Olefin Copolymer, Novel Transition Metal Compound, and Process for Producing Transition Metal Compound MITSUI CHEMICALS, INC. 2007-11-08 US disclosed
CN-101014629-A Catalysts for olefin polymerization, process for production of olefin polymers, olefin copolymers, novel transition metal compounds, and process for production of transition metal compounds MITSUI CHEMICALS INC (JP) 2007-08-08 CN disclosed
EP-1788002-A1 CATALYSTS FOR OLEFIN POLYMERIZATION, PROCESS FOR PRODUCTION OF OLEFIN POLYMERS, OLEFIN COPOLYMERS, NOVEL TRANSITION METAL COMPOUNDS, AND PROCESS FOR PRODUCTION OF TRANSITION METAL COMPOUNDS Mitsui Chemicals, Inc. (JP) 2007-05-23 EP disclosed
US-20050176908-A1 Slipping property imparting agent for clear coating and clear coating paper having the agent applied thereon SAN NOPCO LIMITED (JP) 2005-08-11 US disclosed
EP-0506314-B1 Process for preparing vinylically-unsaturated compounds DOW CHEMICAL CO (US) 2002-01-30 EP disclosed
EP-0190149-B1 STEREOISOMETRICALLY PURE 17-ALPHA-ETHYNYL-ESTRA-2-EN-17BETA-OL AND ESTERS THEREOF SRI INTERNATIONAL (US) 1989-12-13 EP disclosed
US-4788218-A MALE FERTILITY CONTROL SRI INTERNATIONAL (US) 1988-11-29 US disclosed
EP-0254937-A2 Hydroformylation using low volatile/organic soluble phosphine ligands UNION CARBIDE CORPORATION (US) 1988-02-03 EP disclosed
EP-0190149-A1 STEREOISOMETRICALLY PURE 17-ALPHA-ETHYNYL-ESTRA-2-EN-17BETA-OL AND ESTERS THEREOF. STANFORD RES INST INT (US) 1986-08-13 EP disclosed
EP-0182808-A1 17 a?$g(b)-HYDROXY-7$g(a)-METHYL-D-HOMO-19-NORANDROST-4,16-DIENE-3-ONE AND THE 17-ESTERS THEREOF: METHODS OF PREPARATION AND USES SRI INTERNATIONAL (US) 1986-06-04 EP disclosed
WO-1986001208-A1 STEREOISOMETRICALLY PURE 17-ALPHA-ETHYNYL-ESTRA-2-EN-17BETA-OL AND ESTERS THEREOF SRI INTERNATIONAL (US) 1986-02-27 WO disclosed
WO-1985005361-A1 17abeta-HYDROXY-7alpha-METHYL-D-HOMO-19-NORANDROST-4,16-DIENE-3-ONE AND THE 17-ESTERS THEREOF: METHODS OF PREPARATION AND USES SRI INTERNATIONAL (US) 1985-12-05 WO disclosed
US-4338219-A Catalyst compositions used for copolymerization of isomonoolefins with conjugated dienes PHILLIPS PETROLEUM COMPANY (US) 1982-07-06 US disclosed
US-4105845-A NICKEL SOURCE COMPLEX WITH TITANIUM OR VANADIUM COMPOUND PHILLIPS PETROLEUM COMPANY (US) 1978-08-08 US disclosed
US-4036896-A FREE RADICAL CATALYST UNIVERSAL OIL PRODUCTS COMPANY (US) 1977-07-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100267908-A1 Catalyst for olefin polymerization, process for producing olefin polymer, olefin copolymer, novel transition metal compound, and process for producing transition metal compound RB1, POF1B, CCNA1 EPHX1 2902/4885HPGD 2370/4885KMT2A 656/4885
US-20070260026-A1 Catalyst for Olefin Polymerization Process for Producing Olefin Polymer, Olefin Copolymer, Novel Transition Metal Compound, and Process for Producing Transition Metal Compound POF1B, RB1, CCNA1 EPHX1 3143/4885HPGD 2655/4885KMT2A 720/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.